Retrieving results for synthetic complete for BY4743, please wait...
Enter orf / gene / drug:
(e.g. pex22 or lovastatin)
synthetic complete for BY4743
Section 1: Phenotypes.
Drug-gene relationships for synthetic complete for BY4743
(Hillenmeyer et al., Science 2008)
The top 10 strains that exhibited a fitness defect in synthetic complete for BY4743. On the left is a table listing the top 10 sensitive strains; on the right is a visualization of those strains. Edges may appear more than once if the condition was tested multiple times.
We generally recommend using a significance cutoff of p-value < 0.01. For the "phenotype for all genes" analysis, we used p-value < 1e-5 to control for multiple hypothesis testing. For details, see
The Chemical Genomic Portrait of Yeast
Heterozygous knockouts inhibited:
[No Heterozygous results.]
Homozygous knockouts inhibited:
Top 10 Homozygous deletion strains inhibited by synthetic complete for BY4743:
...(click to see all Homozygous data)
Enriched GO terms of the top genes/strains
Section 2: Co-inhibition interactions.
Drug-drug relationships for synthetic complete for BY4743
(Hillenmeyer et al., Genome Biol. 2010)
In this study, we have calculated co-inhibition between all pairs of compounds, testing several types of correlation.
Heterozygous co-inhibition interactions
[No heterozygous results.]
Homozygous co-inhibition interactions
[No homozygous results.]
External information about synthetic complete for BY4743
Visit synthetic complete for BY4743 in [
plain text version
of this page.
Pageloads since April 18, 2008
View website stats